These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15044836)

  • 1. The HPV-16 E5 protein inhibits TRAIL- and FasL-mediated apoptosis in human keratinocyte raft cultures.
    Kabsch K; Mossadegh N; Kohl A; Komposch G; Schenkel J; Alonso A; Tomakidi P
    Intervirology; 2004; 47(1):48-56. PubMed ID: 15044836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human papillomavirus type 16 E5 protein impairs TRAIL- and FasL-mediated apoptosis in HaCaT cells by different mechanisms.
    Kabsch K; Alonso A
    J Virol; 2002 Dec; 76(23):12162-72. PubMed ID: 12414956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human papillomavirus type 16 (HPV-16) E5 protein sensitizes human keratinocytes to apoptosis induced by osmotic stress.
    Kabsch K; Alonso A
    Oncogene; 2002 Jan; 21(6):947-53. PubMed ID: 11840340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.
    Konur A; Schulz U; Eissner G; Andreesen R; Holler E
    Br J Dermatol; 2005 Jun; 152(6):1134-42. PubMed ID: 15948973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells.
    Knight MJ; Riffkin CD; Muscat AM; Ashley DM; Hawkins CJ
    Oncogene; 2001 Sep; 20(41):5789-98. PubMed ID: 11593384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex.
    Izeradjene K; Douglas L; Delaney AB; Houghton JA
    Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling events triggered by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): caspase-8 is required for TRAIL-induced apoptosis.
    Seol DW; Li J; Seol MH; Park SY; Talanian RV; Billiar TR
    Cancer Res; 2001 Feb; 61(3):1138-43. PubMed ID: 11221844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells induce the death of human papillomavirus-transformed keratinocytes.
    Hubert P; Giannini SL; Vanderplasschen A; Franzen-Detrooz E; Jacobs N; Boniver J; Delvenne P
    FASEB J; 2001 Nov; 15(13):2521-3. PubMed ID: 11641258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand.
    Ozoren N; Kim K; Burns TF; Dicker DT; Moscioni AD; El-Deiry WS
    Cancer Res; 2000 Nov; 60(22):6259-65. PubMed ID: 11103780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligand reduces viability in primary melanoma short-term cell cultures more than in metastatic melanoma short-term cell cultures.
    Hofbauer GF; Hatta N; Daigle I; Hemmi S; Spanaus Schlapbach K; Willers J; Burg G; Simon HU; Dummer R
    Dermatology; 2005; 211(4):318-24. PubMed ID: 16286739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
    Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
    Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice.
    Hao C; Song JH; Hsi B; Lewis J; Song DK; Petruk KC; Tyrrell DL; Kneteman NM
    Cancer Res; 2004 Dec; 64(23):8502-6. PubMed ID: 15574753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major.
    Eidsmo L; Fluur C; Rethi B; Eriksson Ygberg S; Ruffin N; De Milito A; Akuffo H; Chiodi F
    Am J Pathol; 2007 Jan; 170(1):227-39. PubMed ID: 17200196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining characteristics of Types I and II apoptotic cells in response to TRAIL.
    Ozören N; El-Deiry WS
    Neoplasia; 2002; 4(6):551-7. PubMed ID: 12407450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential induction of apoptosis by tumor necrosis factor-related apoptosis-inducing ligand in human ovarian carcinoma cells.
    Lane D; Cartier A; L'Espérance S; Côté M; Rancourt C; Piché A
    Gynecol Oncol; 2004 Jun; 93(3):594-604. PubMed ID: 15196850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
    Lawrence CP; Chow SC
    FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.